Search Results - Randa M. Abdulrahman

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial

    Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial by Tatiana Schneider, Randa M. Abdulrahman, Eleonora P.M. Corssmit, Hans Morreau, Johannes W. A. Smit, Ellen Kapiteijn

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Sorafenib-Induced Hypothyroidism Is Associated with Increased Type 3 Deiodination

    Sorafenib-Induced Hypothyroidism Is Associated with Increased Type 3 Deiodination by Randa M. Abdulrahman, Herman Verloop, Hendrieke C. Hoftijzer, Erik Verburg, Guido C. Hovens, Eleonora P.M. Corssmit, Christoph Reiners, Hans Gelderblom, Alberto M. Pereira, Ellen Kapiteijn, Johannes A. Romijn, Theo J. Visser, Johannes W. A. Smit

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: